1. Home
  2. EPR vs ADMA Comparison

EPR vs ADMA Comparison

Compare EPR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$50.15

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$19.78

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPR
ADMA
Founded
1997
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.1B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
EPR
ADMA
Price
$50.15
$19.78
Analyst Decision
Buy
Strong Buy
Analyst Count
11
2
Target Price
$57.06
$28.50
AVG Volume (30 Days)
609.7K
2.9M
Earning Date
10-29-2025
11-05-2025
Dividend Yield
7.07%
N/A
EPS Growth
N/A
205.35
EPS
2.29
0.86
Revenue
$707,150,000.00
$488,559,000.00
Revenue This Year
$5.11
$22.19
Revenue Next Year
$2.70
$24.33
P/E Ratio
$21.91
$23.11
Revenue Growth
3.73
27.63
52 Week Low
$41.75
$13.50
52 Week High
$61.24
$25.67

Technical Indicators

Market Signals
Indicator
EPR
ADMA
Relative Strength Index (RSI) 38.11 66.02
Support Level $49.41 $19.13
Resistance Level $51.80 $20.22
Average True Range (ATR) 0.94 0.73
MACD -0.15 0.05
Stochastic Oscillator 20.14 79.44

Price Performance

Historical Comparison
EPR
ADMA

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: